EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

IL-22 in Atopic Dermatitis

Julia Laska, Maciej Tota iD, Julia Łacwik iD, Łukasz Sędek iD, Krzysztof Gomułka iD

Cells · 2024

DOI: 10.3390/cells13161398 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, 2024. Verfasst von Julia Laska und 4 weiteren Autor:innen. Beteiligte Einrichtung: Student Research Group of Microbiology and Immunology, Department of Microbiology and Immunology, Zabrze, Medical University of Silesia in Katowice, …. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Interleukin-22, Interleukins. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 161 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: 60% Silesian Medical University, 40% Wroclaw Medical Universite.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atopic dermatitis (AD) is a prevalent and chronic inflammatory skin condition characterized by a multifaceted pathophysiology that gives rise to diverse clinical manifestations. The management of AD remains challenging due to the suboptimal efficacy of existing treatment options. Nonetheless, recent progress in elucidating the underlying mechanisms of the disease has facilitated the identification of new potential therapeutic targets and promising drug candidates. In this review, we summarize the newest data, considering multiple connections between IL-22 and AD. The presence of circulating IL-22 has been found to correlate with the severity of AD and is identified as a critical factor driving the inflammatory response associated with the condition. Elevated levels of IL-22 in patients with AD are correlated with increased proliferation of keratinocytes, alterations in the skin microbiota, and impaired epidermal barrier function. Collectively, these factors contribute to the manifestation of the characteristic symptoms observed in AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicInterleukin-22InterleukinsHumansAnimalsKeratinocytesSkinMicrobiota

Stichwörter der Autor:innen

ADTh22atopic dermatitisfezakinumabinfectionsinterleukin-22skin barrierwound healing

Substanzen

Interleukin-22Interleukins

Autor:innen und Institutionen

  • Student Research Group of Microbiology and Immunology, Department of Microbiology and Immunology, Zabrze, Medical University of Silesia in Katowice, 40-055 Katowice, Poland.
  • Student Research Group of Internal Medicine and Allergology, Clinical Department of Internal Medicine, Pneumology and Allergology, Wroclaw Medical University, 50-369 Wrocław, Poland.
  • Department of Microbiology and Immunology, Zabrze, Medical University of Silesia in Katowice, 40-055 Katowice, Poland.
  • Clinical Department of Internal Medicine, Pneumology and Allergology, Wroclaw Medical University, 50-369 Wrocław, Poland.

ORCID-Profile: Maciej Tota, Julia Łacwik, Łukasz Sędek, Krzysztof Gomułka

Förderung

  • 60% Silesian Medical University, 40% Wroclaw Medical Universite

Zitieren

APA

Laska, J., Tota, M., Łacwik, J., Sędek, Ł., & Gomułka, K. (2024). IL-22 in Atopic Dermatitis. Cells. https://doi.org/10.3390/cells13161398

Vancouver

Laska J, Tota M, Łacwik J, Sędek Ł, Gomułka K. IL-22 in Atopic Dermatitis. Cells. 2024. doi:10.3390/cells13161398

BibTeX
@article{Laska2024,
  author = {Laska, Julia and Tota, Maciej and Łacwik, Julia and Sędek, Łukasz and Gomułka, Krzysztof},
  title = {IL-22 in Atopic Dermatitis},
  journal = {Cells},
  year = {2024},
  doi = {10.3390/cells13161398}
}
Kostenlos starten →